Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Departments of Pharmacology & Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Immunotherapy. 2021 May;13(7):561-564. doi: 10.2217/imt-2021-0012. Epub 2021 Mar 16.
Tweetable abstract US FDA-approved immune checkpoint inhibitors have limited efficacy for gastrointestinal cancers such as #colorectalcancer and #pancreaticcancer. Could combinations with experimental cancer 'vaccines' be the key?
美国食品和药物管理局批准的免疫检查点抑制剂对胃肠道癌症(如结直肠癌和胰腺癌)的疗效有限。与实验性癌症“疫苗”联合使用是否是关键?